(Q36392401)

13 August 2017

1 reference

title

Metabolic therapeutics in angina pectoris: history revisited with perhexiline (English)

1 reference

13 August 2017

Sally Inglis

1

1 reference

PubMed ID

16469541

13 August 2017

Simon Stewart

series ordinal

2

1 reference

13 August 2017

15 February 2006

1 reference

European Journal of Cardiovascular Nursing

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

2

1 reference

13 August 2017

175-184

1 reference

The current cost of angina pectoris to the National Health Service in the UK.

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Refractory angina pectoris: mechanism and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Metabolic manipulation in ischaemic heart disease, a novel approach to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Relationship between plasma perhexiline concentration and symptomatic status during short-term perhexiline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Partial fatty acid oxidation inhibitors for stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Energy metabolism in the normal and failing heart: potential for therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Role of insulin-glucose infusion in outcomes after acute myocardial infarction: the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Pharmacogenetics and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

Studies on the metabolism of perhexiline in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

High-Performance Liquid Chromatographic Assay of Perhexiline Maleate in Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJCNURSE.2006.01.001

10.1016/J.EJCNURSE.2006.01.001

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16469541